Tyra Biosciences, Inc.
TYRA
$20.92
$0.110.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.37% | -30.86% | -27.82% | -25.09% | -41.46% |
| Total Depreciation and Amortization | 16.98% | 27.94% | 36.36% | 45.38% | 41.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.74% | 78.21% | 53.85% | 37.78% | 17.06% |
| Change in Net Operating Assets | -174.61% | -185.83% | 310,600.00% | -111.46% | 364.06% |
| Cash from Operations | -42.99% | -37.58% | -17.46% | -39.16% | -31.14% |
| Capital Expenditure | 92.86% | 92.03% | 37.34% | 13.77% | -570.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 118.16% | 130.17% | 33.21% | 32.05% | -- |
| Cash from Investing | 118.03% | 129.99% | 33.24% | 31.95% | -132,771.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.96% | -97.91% | -97.89% | 13,078.72% | 16,526.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -48.52% | -- | -- |
| Cash from Financing | -97.96% | -97.91% | -98.01% | 13,051.40% | 16,491.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.47% | 99.25% | -1,313.15% | 117.58% | -134.99% |